Stereotactic Surgery Devices Market Size, Insights, Outlook, Overview By 2024-2033

Overview and Scope

A stereotactic surgical device is a technology that employs a set of three coordinates to precisely locate brain parts while the head is in a fixed position. It is used in stereotactic surgery to implant things into the brain, such as medications or hormones.

Sizing and Forecast

The stereotactic surgery devices market size has grown steadily in recent years. It will grow from $21.43 billion in 2023 to $22.41 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%.  The  growth in the historic period can be attributed to shift towards minimally invasive procedures, integration of robotics and automation, increased demand for precision and accuracy, improved safety profiles.

The stereotactic surgery devices market size is expected to see steady growth in the next few years. It will grow to $27.21 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%.  The growth in the forecast period can be attributed to rising cases of cancer, ai and machine learning integration, expansion to new medical specialties, rise in geriatric population, customization and personalization in treatments. Major trends in the forecast period include precision and accuracy improvement, miniaturization of devices, robotics and automation, personalized treatment approaches, expanded applications and procedures.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/stereotactic-surgery-devices-global-market-report

Segmentation & Regional Insights

The stereotactic surgery devices market covered in this report is segmented –

1) By Product: Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam, CyberKnife

2) By Application: Brain Tumor Treatment, Arteriovenous Malformations Treatment, Parkinsons Disease, Epilepsy, Other Applications

3) By End User: Hospitals, Laboratories

North America was the largest region in the stereotactic surgery devices market in 2023. The regions covered in the stereotactic surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

 Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10495&type=smp

Major Driver Impacting Market Growth

The increasing number of Parkinson’s disease and epilepsy are expected to boost the growth of the stereotactic surgical device market going forward. Parkinson’s disease is a neurodegenerative illness that causes involuntary shaking, sluggish movement, and stiff, inflexible muscles, whereas epilepsy is a neurological ailment that affects the brain and renders patients more susceptible to experiencing recurring, unprovoked seizures. Stereotactic surgical devices are used to treat movement disorders, epilepsy, pain, and psychiatry, as well as Parkinson’s disease. For instance, as per the study revealed by the Parkinson’s Foundation, a New York-based national nonprofit organization, in 2022, in the United States, over 90,000 people will be diagnosed with Parkinson’s disease each year. This is a 50% rise from the previously expected yearly rate of 60,000 diagnoses. Parkinson’s disease (PD) affects almost a million people in the United States. By 2030, to increase to 1.2 million. Therefore, increasing cases of Parkinson’s disease and epilepsy are driving the growth of the stereotactic surgical device market.

Key Industry Players

Major companies operating in the stereotactic surgery devices market report are Alliance Oncology, Micromar Industria Commercio Ltda., Adeor Medical AG, Monteris Medical Holding AG, Inomed Medizintechnik GmbH, Ion Beam Applications S.A. (IBA), Elekta AB (publ), Varian Medical Systems Inc., Accuracy Incorporated, Modus Medical Devices Inc., Koninklijke Philips N.V., Huiheng Group Co. Ltd., Mitsubishi Heavy Industries Ltd., GE Healthcare, Siemens AG, Medtronic plc, Brainlab AG, Renishaw plc, Neuropace Inc., Microvention Inc., MR Solutions Ltd., RaySearch Laboratories AB, Alpha Omega Engineering Inc., FHC Inc., Nexstim Plc, Scopis GmbH, IZI Medical Products LLC, Integra LifeSciences Holdings Corporation, Computerized Imaging Reference Systems Inc., MRI Interventions Inc., ZAP Surgical Systems Inc., Schaerer Medical USA Inc.

The stereotactic surgery devices  market report table of contents includes:

1. Executive Summary
2. Stereotactic Surgery Devices Market Characteristics
3. Stereotactic Surgery Devices Market Trends And Strategies
4. Stereotactic Surgery Devices Market – Macro Economic Scenario
5. Global Stereotactic Surgery Devices Market Size and Growth
…
31. Global Stereotactic Surgery Devices Market Competitive Benchmarking
32. Global Stereotactic Surgery Devices Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Stereotactic Surgery Devices Market
34.Stereotactic Surgery Devices Market Future Outlook and Potential Analysis
35. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model